Pfizer Inc. (NYSE:PFE) stock had its “buy” rating reiterated by The Street in a research note issued on Tuesday, Analyst Ratings News reports. The analysts wrote, “Pfizer (PFE) has been reiterated by The Street Ratings as a buy with a ratings score of A. The company’s strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, expanding profit margins and increase in stock price during the past year. Pfizer Inc. (NYSE:PFE) stock opened at $32.12 in last session, and closed at $32.11, while the day range of Pfizer Inc. (NYSE:PFE) stock is $31.85 – $32.41. The stock showed a positive weekly performance of 2.07%.
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company’s pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) stock opened at $1.33 in last session, and closed at $1.35 by gaining 0.00%. The 52 week range of $0.28 – $1.85. Company’s market capitalization is $176.13M.
Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Cowen and Company 34th Annual Healthcare Conference on March 4 in Boston. Boston Scientific Corporation (NYSE:BSX) stock decreased -1.50% and finished the last session at $13.10. The EPS of the stock remained -0.09. Company’s market capitalization is $17.41B.
Shares of MannKind Corporation (NASDAQ:MNKD) saw unusually large options trading activity on Monday. Stock traders acquired 12,443 call options on the stock, Stock Ratings Network reports. MannKind Corporation (NASDAQ:MNKD) stock opened the session at $6.26, and closed the session at $6.19. The 52 week range of the MannKind Corporation (NASDAQ:MNKD) stock remained $2.54 – $8.70 and the day range was $5.94 – $6.34.